Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year
Hypertension March 8, 2021 Otto Simonsson, Peter S. Hendricks, Robin Carhart-Harris et al. 36 citations
Adults who had used a classic psychedelic at least once in their lifetime had 14% lower odds of hypertension in the past year, after adjusting for confounders. The association was strongest for tryptamine psychedelics (DMT, ayahuasca, psilocybin), which were linked to 20% lower odds of hypertension. No significant association was found for LSD or mescaline. The authors note these findings are correlational and call for randomized controlled trials to test causal effects.